Medical News Today12h
EBGLYSS for eczema: What to know about the newly FDA-approved drug from Eli Lilly
The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...
Food Safety News1h
Publisher’s Platform: Will the FDA use its recall authority to mandate a pet food recall due to Salmonella and Listeria?
The FDA has issued a similar warning for some Answers brand pet food. The manufacturer, Lystn LLC, has not issued a recall, ...
FDA Issues Urgent Warning After Popular Natural Dog Food Tests Positive for Salmonella
The FDA notice cautions pet parents that after five products from Darwin's Natural Pet Products raw dog and cat food made by ...
Food Safety News1h
FDA supports EU’s WGS outbreak plan; food industry groups voice concerns
The U.S. Food and Drug Administration (FDA) has backed European plans to use whole genome sequencing (WGS) to help solve ...
Nasal spray flu vaccine gets FDA approval for home use: ‘A good alternative’
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...
At-home flu vaccine authorized by FDA
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
Telegram11h
FDA approves at-home flu vaccine nasal spray. Here's what to know about it.
AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...
ConsumerAffairs8h
FDA approves first at-home nasal spray flu vaccine for the 2-49 age range
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
JD Supra12h
New FDA clinical trials guidances promote efficient drug development, innovative designs, diversity
The U.S. Food and Drug Administration (FDA) issued this week three guidance documents related to clinical trials: a draft ...
FDA grants IND clearance for Innate Pharma’s solid tumour trial
Innate Pharma has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) ...
Medscape21h
FDA Expands Indication for Amivantamab in Lung Cancer
Amivantamab plus chemo is now indicated in locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R ...
Medscape12h
FDA Approves Bimekizumab for Three Rheumatologic Conditions
The US Food and Drug Administration has approved bimekizumab -bkzx (Bimzelx; UCB) for adult patients with active psoriatic ...